M42’s Imperial College London Diabetes & Endocrine Centre and HealthPlus Diabetes and Endocrinology Center Bring Together 1,000+ Experts for Third Annual Diabetes & Endocrine Conference
The Imperial College London Diabetes & Endocrine Centre (ICLDEC) and HealthPlus Diabetes & Endocrinology Center, both part of the M42 group, successfully concluded the 3rd Annual Diabetes & Endocrine Conference. The two-day event brought together a diverse spectrum of healthcare professionals – from specialist physicians and clinical researchers to nurses, educators and allied health experts – from across the globe to advance diabetes and endocrine management and patient care through education, collaboration, and innovation, the defining themes of this year’s conference.
Building on the success of the first two editions, this year’s conference convened over 1,000 delegates from seven countries, including hospitals, academic institutions, research centres, and industry leaders. Attendees immersed themselves in a dynamic scientific program featuring keynote lectures, interactive case studies, and comprehensive workshops. The conference’s expanded agenda reflected its new, broader scope, incorporating key endocrine topics and underscoring the close interplay between diabetes, hormonal health, and metabolic disorders.
Dr. Mai Ahmed Al Jaber, CEO of Outpatient Care, M42, said: “Our annual conference, held in partnership with the UK’s renowned Imperial College London, has become a vital platform for shaping the future of diabetes and endocrine care. By empowering healthcare professionals with the latest clinical evidence, emerging technologies, and opportunities for meaningful collaboration, we are not only improving patient outcomes but also driving a collective movement towards innovation, education, and long-term impact in diabetes and endocrine management.”
Through a rich, two-day scientific program blending clinical depth with hands-on learning, the 3rd Annual Diabetes & Endocrine Conference delivered an unparalleled platform for advancing clinical expertise. The first day focused on practical diabetes management, featuring sessions on paradigm shifts in Type 2 Diabetes treatment, new approaches to obesity care, and updates on diabetic retinopathy. The day culminated in a lively debate on bariatric surgery and its evolving role in obesity management, alongside parallel workshops that brought real cases from Type 1, Type 2, Pituitary, and Thyroid Clinics to life, allowing delegates to apply insights directly to complex patient scenarios.
The second day expanded into key areas of endocrinology, exploring precision medicine in diabetes, genetics, poly-cystic ovarian syndrome (PCOS) management, and bone health. Sessions also highlighted the growing influence of artificial intelligence, machine learning, and data-driven decision-making in personalising endocrine and metabolic care. The program concluded with discussions on cardiometabolic disease management and innovative therapies addressing dyslipidemia and osteoporosis, reinforcing the conference’s multidisciplinary approach and its newly broadened focus on endocrine health.
Prof. Amir H. Sam, Conference Chair and Head of Imperial College School of Medicine, said: “This conference highlights the power of shared expertise and multidisciplinary collaboration in advancing diabetes and endocrinology. By bringing together leading minds from diverse fields and across the globe, we are transforming cutting-edge research into meaningful clinical impact, and fostering a worldwide community dedicated to improving patient care through innovation and education.”
The spirit of collaboration and continuous learning resonated strongly among attendees, many of whom emphasised the event’s tangible impact on their professional development. One participant, Dr. Mariam Al Hosani, Family Medicine Consultant, commented: “What stood out most was how practical and interactive the sessions were. The case-based workshops and peer-to-peer exchanges brought complex scenarios to life, equipping us with practical tools and strategies we can immediately apply in patient care.”
Another delegate, Richard Flanagai, Nurse Manager, said: “The conference offered an incredible opportunity to connect cutting-edge research with clinical practice. The depth of discussion around emerging therapeutics, AI integration, and real-world data applications provided invaluable insights that will directly inform and strengthen diabetes care.”
The 3rd Annual Diabetes & Endocrine Conference concluded with a renewed sense of purpose and collaboration, uniting the world’s healthcare community in advancing the standards of diabetes and endocrine prevention, management, and patient care. As part of Diabetes Awareness Month, M42 and its network will continue to engage the wider community through a series of public health initiatives, including the Annual Diabetes Walk, scheduled to take place from 6:00am on Sunday, November 23 at Zayed Sports City. Members of the public are encouraged to take part and join healthcare professionals in raising awareness, promoting active living, and supporting the shared goal of reducing the impact of diabetes across the UAE.
